Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02978521 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pulmonary Rehabilitation in Advanced Non-small Cell Lung Cancer Patients

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 5, 2025 to Dec 5, 2026
    • Study completion date: Dec 12, 2025 to Dec 12, 2027
    • Site details revised
    v7
  2. Primary completion date: Dec 5, 2024 to Dec 5, 2025v6
  3. Primary completion date: Aug 5, 2024 to Dec 5, 2024v5
  4. Re-verified, no change to tracked fieldsv4
  5. Secondary endpoints: details revised at 1 of 6 entriesv3
  6. Primary completion date: Aug 2018 to Aug 5, 2024v2 Show 4 more changesShow less
    • Study completion date: Oct 2018 to Dec 12, 2025
    • Start date: Aug 2016 to Aug 5, 2016
    • Secondary endpoints revised (6)
    • Site details revised
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Lung cancer (LC) is usually diagnosed in advanced stages and continues to be the leading cause of cancer related deaths worldwide. Cancer cachexia are frequent among patients with LC affecting up to 80% of patients with advanced stage disease, and it has been related with higher risk of complications, length of hospital stay, and worst overall survival. During cancer cachexia, both muscle and fat mass can be wasted, however, the loss of muscle mass has been associated to higher treatment related toxicity, loss of functional status, shorter progression free survival and overall survival in different types of cancer under various treatments. Hence, preservation of muscle mass and function should be an important focus of the multidisciplinary treatment of patients with LC. Pulmonary rehabilitation (PR) has been known to improve pulmonary function, reduce fatigue and improve exercise tolerance in patients with LC undergoing curative surgery. However, few studies have focused on the efficacy of PR on patients with advanced cancer undergoing palliative care with chemotherapy or targeted therapies.
Trial Details
NCT Number NCT02978521
Lead Sponsor Instituto Nacional de Cancerologia de Mexico
Conditions
(from sponsor)		 Pulmonary Rehabilitation, Sarcopenia, Quality of Life
Related terms Sarcopenia
Enrollment 94 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov